AFT Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
AFT Pharmaceuticals is a dividend paying company with a current yield of 0.59%.
Key information
0.6%
Dividend yield
-0.0004%
Buyback Yield
| Total Shareholder Yield | 0.6% |
| Future Dividend Yield | 1.3% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NZ$0.016 |
| Payout ratio | 16% |
Recent dividend and buyback updates
Recent updates
AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 17
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year
Jul 26AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
May 25Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?
May 22Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?
Oct 17Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?
May 23Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?
Dec 01We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise
Jul 30With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For
Jun 02Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?
Mar 20A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation
Feb 13
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 23Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?
Jan 02Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?
Dec 12AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: AFT is not paying a notable dividend for the NZ market, therefore no need to check if payments are stable.
Growing Dividend: AFT is not paying a notable dividend for the NZ market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| AFT Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AFT) | 0.6% |
| Market Bottom 25% (NZ) | 3.3% |
| Market Top 25% (NZ) | 6.4% |
| Industry Average (Pharmaceuticals) | 2.3% |
| Analyst forecast (AFT) (up to 3 years) | 1.3% |
Notable Dividend: AFT's dividend (0.59%) isn’t notable compared to the bottom 25% of dividend payers in the NZ market (3.32%).
High Dividend: AFT's dividend (0.59%) is low compared to the top 25% of dividend payers in the NZ market (6.39%).
Earnings Payout to Shareholders
Earnings Coverage: AFT is not paying a notable dividend for the NZ market.
Cash Payout to Shareholders
Cash Flow Coverage: AFT is not paying a notable dividend for the NZ market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/28 22:34 |
| End of Day Share Price | 2025/02/28 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AFT Pharmaceuticals Limited is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | Bell Potter |
| Jack Crowley | Credit Suisse |
| Soo Romanoff | Edison Investment Research |